Candela receives registration approval to market products in China

The SFDA (State Food and Drug Administration) of China has approved the Alex TriVantage multi-wavelength, Q-switched laser system and the GentleMax multiple wavelength workstation from Candela for sale throughout the People's Republic of China, including Hong Kong.

The SFDA (State Food and Drug Administration) of China has approved the Alex TriVantage multi-wavelength, Q-switched laser system and the GentleMax multiple wavelength workstation from Candela for sale throughout the People's Republic of China, including Hong Kong. The receipt of the SFDA Certificates will allow the company to begin the sales process and launch official marketing programs for these products.

The Q-switched Laser-Pumped-Laser (LPL) technology of the Alex TriVantage laser provides 755-nm, 532-nm and 1064-nm output wavelengths. The addition of a long-pulse mode at 755 nm offers advanced treatments for a wider variety of pigmented lesions (many unique to Asian skin) without long-term side effects. Beyond the treatment of benign pigmented lesions and the removal of multi-color tattoo inks, the product reportedly enhances the results of many skin rejuvenation treatments.

The GentleMax laser system features both 755-nm and 1064-nm wavelengths and may be used to provide permanent hair reduction on all skin types and tanned skin as well as the treatment of vascular and pigmented lesions, wrinkle reduction and skin tightening.

For more information on these lasers, visit www.candelalaser.com.

More in Biomedicine